Table 1 Demography, clinical and laboratory data of the studied SLE patients

Age (years)

29.45 ± 8.6

28.8 ± 9.7

0.5

0.6

Age of onset

26.8 ± 8.9

26.6 ± 8.7

0.3

0.9

Duration of the disease

2.6 ± 2.3

2.7 ± 2.1

0.2

0.8

Systolic BP

120.4 ± 15.5

122.9 ± 16.1

0.8

0.3

Diastolic BP

77.6 ± 10.5

79.3 ± 10.7

0.1

0.7

n

%

n

%

Female

91

91

71

73.2%

0.01

0.9

Male

9

9%

8

26.8%

Mucocutenous

91

91%

79

100%

0.01

0.9

Serositis

26

26%

23

29.1%

0.2

0.7

Lupus nephritis

64

64%

43

54.4%

1.6

0.2

CNS affection (other than headache)

7%

7%

2

2.5%

1.8

0.3

Arthritis

59

59%

47

59.4%

0.04

0.9

aPL positivity

34

34%

28

35.4%

0.04

0.8

Anti-cardiolipins

31

31%

26

32.9%

0.07

0.7

ANA positive

100

100%

100

100%

…….

…….

Creatinine

1.1 ± 0.9

1.2 ± 1.0

0.7

0.4

Anti-ds DNA

256.5 ± 323.4

202.6 ± 201.8

1.2

0.1

UPCR (g protein\mg creat)

1.7 ± 2.6

2.1 ± 2.8

0.6

0.4

SLEDAI

6.1 ± 5.7

2.7 ± 1.3

5.1

< 0.0001*